Speeches & presentations

Cowen 37th Annual Healthcare Conference

Axel Hoos, SVP – Oncology R&D, gave a presentation at the Cowen and Company 37^th Annual Health Care Conference  in Boston. Axel provided an overview of GSK’s Oncology strategy and pipeline.

• Cowen 37th Annual Healthcare Conference - slides PDF - 1.3MB

Investor event at CROI 2017, Seattle

ViiV Healthcare Chairman David Redfern, CEO Dominique Limet and Chief Scientific and Medical Officer John Pottage, hosted an investor event following the presentation of the SWORD Phase III data at the Conference on Retroviral and Opportunistic Infections.

• HIV analyst call presentation PDF - 938.4KB
• CROI analyst call transcript PDF - 437.5KB

35th annual JP Morgan Healthcare Conference, San Francisco, USA

Dr Patrick Vallance, President, R&D gave a presentation at the 35th annual JP Morgan Healthcare Conference in San Francisco, providing an overview of the company’s pharmaceutical pipeline.

• 2017 JPM Patrick Vallance presentation PDF - 1.1MB
• 2017 JPM Patrick Vallance transcript PDF - 176.9KB

Meet the Vaccines management

Luc Debruyne and his leadership team hosted an investor event to review the Vaccines business. This event included a tour of the Wavre site, presentations from Luc Debruyne, Thomas Breuer, Manu Hanon and John McGrath, followed by a Q&A session.

• GSK vaccines meet the management presentation PDF - 4.9MB
• GSK vaccines meet the management transcript PDF - 325.9KB

HIV and ViiV Healthcare presentation to Goldman Sachs

Seminar on the evolving scientific and commercial landscape for HIV and ViiV Healthcare. Presentation by Dr Dominique Limet and Dr John Pottage followed by a Q&A session.

• Goldman Sachs seminar on HIV and ViiV healthcare presentation PDF - 1.3MB
• Goldman Sachs seminar on HIV and ViiV healthcare transcript PDF - 439.1KB

Meet The Respiratory Management event

Prior to the 2016 ERS conference, senior respiratory leaders Eric Dube, Neil Barnes and Dave Allen hosted an investor event with presentations and a Q&A session to review the Respiratory business.

• Meet the respiratory management presentation PDF - 3.3MB
• Meet the respiratory management transcript PDF - 282.9KB

Goldman Sachs 37th Annual Global Healthcare Conference

Simon Dingemans, Chief Financial Officer, participated in a fireside chat to discuss progress on GSK’s business strategy and addressed questions before a large group of investors at the Goldman Sachs Conference in California on Wednesday, 8 June 2016.

• Goldman Sachs 37th annual global healthcare conference transcript PDF - 120.3KB

Citi Healthcare Bus Tour, New York

Dr. Axel Hoos, SVP, Therapeutic Area Head for Oncology R&D and Head of Immuno-Oncology, hosted an investor event organized by Citi at their offices in New York. Axel provided an overview of GSK’s strategy and pipeline in Immuno-Oncology.

• Dr Axel hoos transcript PDF - 863.9KB

Leerink Partners 5th Annual Global Healthcare Conference

Simon Dingemans, Chief Financial Officer, addressed questions in front of a large group of US investors at the Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10 in New York. Simon provided an overview of GSK’s 2015 full year results and outlook for the future. The webcast of the event will be archived for 90 days.

• Leerink Partners 5th annual global healthcare conference transcript DOCX - 29.4KB

34th Annual JP Morgan Healthcare Conference, San Francisco USA

Andrew Witty, CEO, gave a presentation at the 34th Annual JP Morgan Healthcare Conference in San Francisco, providing an overview of progress the company has made during 2015.

• Andrew Witty JP Morgan presentation PDF - 920.7KB
• Andrew Witty JP Morgan transcript PDF - 304.1KB

David Redfern

David Redfern, Chief Strategy Officer, discusses the two transactions with Bristol-Myers Squibb to acquire their late-stage HIV pipeline assets and also their pre-clinical and discovery stage research assets.

• ViiV-BMS investor transcript PDF - 173.8KB

R&D event

On Tuesday 3 November, we hosted an event focusing on our R&D pipeline. This provided a unique insight into the innovative medicines and vaccines that GSK is developing for the future.

• R&D event full presentation PDF - 4.3MB
• R&D event full transcript PDF - 528.4KB
• R&D event Andrew Witty introduction presentation PDF - 564.2KB
• R&D event Andrew Witty introduction transcript PDF - 37.7KB
• Dr Patrick Vallance HIV, infectious diseases, respiratory, PHI presentation PDF - 1.6MB
• Dr Patrick Vallance HIV, infectious diseases, respiratory, PHI transcript PDF - 238.2KB
• Dr Patrick Vallance immuno-inflammation, oncology, rare diseases presentation PDF - 2.0MB
• Dr Patrick Vallance immuno-inflammation, oncology, rare diseases transcript PDF - 168.1KB
• Dr Moncef Slaoui vaccines business presentation PDF - 736.7KB
• Dr Moncef Slaoui vaccines business transcript PDF - 101.3KB

Investor event

The Investor event outlined the Group’s strategy for 2015 and beyond including presentations from the heads of our Vaccines, Pharmaceuticals and Consumer businesses together with Sir Andrew Witty, Chief Executive Officer and Simon Dingemans, Chief Financial Officer.

• Investor event full presentation PDF - 3.0MB
• Investor event full transcript PDF - 305.5KB
• Andrew Witty strategic outlook presentation PDF - 382.0KB
• Andrew Witty strategic outlook transcript PDF - 35.9KB
• Dr Moncef Slaoui vaccines business presentation PDF - 949.9KB
• Dr Moncef Slaoui vaccines business transcript PDF - 67.0KB
• Abbas Hussain pharmaceuticals business presentation PDF - 890.5KB
• Abbas Hussain pharmaceuticals business transcript PDF - 44.2KB
• Emma Walmsley consumer healthcare presentation PDF - 1.4MB
• Emma Walmsley consumer healthcare transcript PDF - 41.9KB
• Simon Dingemans financial outlook presentation PDF - 321.3KB
• Simon Dingemans financial outlook transcript PDF - 37.9KB

33rd Annual JP Morgan Healthcare Conference

David Redfern, Chief Strategy Officer, gave a presentation at the 33th Annual JP Morgan Healthcare Conference in San Francisco.

• 33rd Annual JP Morgan healthcare conference full presentation PDF - 1.4MB
• 33rd Annual JP Morgan healthcare conference full transcript PDF - 98.3KB

Bank of America Merrill Lynch Global Healthcare Conference, London UK

Simon Dingemans, Chief Financial Officer, gave a presentation at the Bank of America Merrill Lynch Global Healthcare conference in London on 19th September 2014. Simon provided an overview of the recent results and the shape of the company going forward.

• Bank of America healthcare conference PDF - 683.3KB

Investor Event at ERS 2014, Munich

Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a presentation and Q&A session based on data presented at ERS.

• ERS investor briefing presentation PDF - 1.0MB
• ERS investor briefing transcript PDF - 327.3KB

Citi Global Healthcare Conference, New York USA

Andrew Witty, CEO, presented at the Citi Global Healthcare Conference on February 24, 2014 in New York. Andrew opened with a few minutes of brief remarks followed by a 'fireside chat' question and answer session.

32nd Annual JP Morgan Healthcare Conference, San Francisco USA

Simon Dingemans, Chief Financial Officer, gave a presentation at the 32nd Annual JP Morgan Healthcare Conference in San Francisco. Simon provided an overview of the progress being made in implementing the company’s strategy.

• JP Morgan healthcare conference 2014 presentation PDF - 555.9KB
• JP Morgan healthcare conference 2014 transcript PDF - 83.6KB
• JP Morgan healthcare conference 2014 transcript Q&A PDF - 114.2KB

Leerink Swann PolarXpress, Philadelphia

Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event organized by Leerink Swann at the GSK offices in Philadelphia.

• Leerink Swann polarxpress 2013 PDF - 1.9MB

North Carolina CEO Forum

Deirdre Connelly, President, North America Pharmaceuticals, spoke at the North Carolina CEO Forum about the importance of curiosity, vision, flexibility, and risk-taking to create a high-performing, innovative, and sustainable business.

• North Carolina CEO forum speech 2013 PDF - 74.0KB